Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1
- PMID: 11279521
- DOI: 10.1038/86898
Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1
Abstract
Neurofibromatosis type 1 (NF1) is a commonly inherited autosomal dominant disorder. Previous studies indicated that mice homozygous for a null mutation in Nf1 exhibit mid-gestation lethality, whereas heterozygous mice have an increased predisposition to tumors and learning impairments. Here we show that mice lacking the alternatively spliced exon 23a, which modifies the GTPase-activating protein (GAP) domain of Nf1, are viable and physically normal, and do not have an increased tumor predisposition, but show specific learning impairments. Our findings have implications for the development of a treatment for the learning disabilities associated with NF1 and indicate that the GAP domain of NF1 modulates learning and memory.
Comment in
-
A particular GAP in mind.Nat Genet. 2001 Apr;27(4):354-5. doi: 10.1038/86835. Nat Genet. 2001. PMID: 11279509 No abstract available.
Similar articles
-
A mouse model for the learning and memory deficits associated with neurofibromatosis type I.Nat Genet. 1997 Mar;15(3):281-4. doi: 10.1038/ng0397-281. Nat Genet. 1997. PMID: 9054942
-
Reduced neurofibromin content but normal GAP activity in a patient with neurofibromatosis type 1 caused by a five base pair duplication in exon 12b of the NF1 gene.Biochem Biophys Res Commun. 1995 Sep 25;214(3):895-904. doi: 10.1006/bbrc.1995.2371. Biochem Biophys Res Commun. 1995. PMID: 7575561
-
A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.Glia. 2007 Aug 15;55(11):1123-33. doi: 10.1002/glia.20534. Glia. 2007. PMID: 17597122
-
Neurofibromatosis type 1.Genet Couns. 1994;5(3):225-41. Genet Couns. 1994. PMID: 7811422 Review.
-
Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.Biochem Pharmacol. 2006 Nov 30;72(11):1485-92. doi: 10.1016/j.bcp.2006.04.010. Epub 2006 Apr 28. Biochem Pharmacol. 2006. PMID: 16797490 Review.
Cited by
-
Altered motor learning and coordination in mouse models of autism spectrum disorder.Front Cell Neurosci. 2023 Nov 8;17:1270489. doi: 10.3389/fncel.2023.1270489. eCollection 2023. Front Cell Neurosci. 2023. PMID: 38026686 Free PMC article. Review.
-
PTEN dosage is essential for neurofibroma development and malignant transformation.Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19479-84. doi: 10.1073/pnas.0910398106. Epub 2009 Oct 21. Proc Natl Acad Sci U S A. 2009. PMID: 19846776 Free PMC article.
-
Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras.Hum Mol Genet. 2006 Apr 1;15(7):1087-98. doi: 10.1093/hmg/ddl023. Epub 2006 Mar 2. Hum Mol Genet. 2006. PMID: 16513807 Free PMC article.
-
Cardiac and vascular functions of the zebrafish orthologues of the type I neurofibromatosis gene NFI.Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22305-10. doi: 10.1073/pnas.0901932106. Epub 2009 Dec 4. Proc Natl Acad Sci U S A. 2009. PMID: 19966217 Free PMC article.
-
The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.Am J Med Genet A. 2012 Sep;158A(9):2225-32. doi: 10.1002/ajmg.a.35535. Epub 2012 Jul 20. Am J Med Genet A. 2012. PMID: 22821737 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
